Physician

Lindsey Morgan Nordstrom O'Brien, MD

According to 2025 Medicare claims, Lindsey O'Brien, MD (NPI: 1427291384) practices hematology/oncology in the Winchester, VA-WV market, with the plurality of this provider's patient population coming from Winchester City, VA. This provider's primary affiliated billing organization is SHENANDOAH ONCOLOGY, PC (NPI: 1124381959; TIN: 454759270) and primary practice location at 22601-6906. O'Brien is affiliated with the ACO West Virginia (ACO ID: A3563) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

O'Brien's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 565 traditional Medicare patients, billed 124,584 HCPCS/CPT codes, and received $2,248,482 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,162 prescription claims across 228 beneficiaries totaling $1,660,988 in drug costs, led by Lenalidomide (Lenalidomide). 2023 DME data shows 14 claims. Open Payments data shows 3 records totaling $72. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $326,710 to $2,248,482. Similarly, Part D prescription costs have risen steadily, from $72,059 to $1,660,988. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	204	20,033	$326,710
2016	453	82,146	$1,013,337
2017	565	109,505	$1,521,554
2018	589	114,348	$1,699,358
2019	819	188,982	$2,865,896
2020	689	164,901	$2,844,324
2021	666	144,454	$2,305,060
2022	593	117,378	$2,154,885
2023	501	105,813	$2,189,838
2024	565	124,584	$2,248,482

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	47	127	$72,059
2016	91	467	$531,893
2017	128	659	$559,308
2018	145	752	$1,009,107
2019	180	900	$916,260
2020	182	906	$1,274,616
2021	192	833	$1,161,652
2022	193	1,072	$956,067
2023	199	1,018	$979,201
2024	228	1,162	$1,660,988

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	15	$542
2017	N/R	N/R	N/R
2018	N/R	12	$226
2019	38	91	$10,621
2020	N/R	81	$5,058
2021	11	107	$5,833
2022	N/R	145	$4,208
2023	N/R	14	$3,387
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	145	384	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	147	169	$60
96375	Injection of additional new drug or substance into vein	111	675	$12
80053	Blood test, comprehensive group of blood chemicals	160	468	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	198	621	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	39	903	$409,595
Bosulif	Bosutinib	14	420	$278,130
Revlimid	Lenalidomide	14	315	$205,895
Imatinib Mesylate	Imatinib Mesylate	17	510	$49,645
Eliquis	Apixaban	63	2,537	$48,237

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$72	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Lindsey Morgan Nordstrom O'Brien, MD?

Tedicare shows public-source Medicare data for Lindsey Morgan Nordstrom O'Brien, MD (NPI 1427291384), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lindsey Morgan Nordstrom O'Brien, MD have ACO affiliation data?

Lindsey Morgan Nordstrom O'Brien, MD is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Lindsey Morgan Nordstrom O'Brien, MD?

Lindsey Morgan Nordstrom O'Brien, MD is linked to SHENANDOAH ONCOLOGY, PC (billing NPI 1124381959) in the available physician profile data.

Does Lindsey Morgan Nordstrom O'Brien, MD have Open Payments data?

Lindsey Morgan Nordstrom O'Brien, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.